Results for tag: "Abciximab"

Abciximab is a hematological drug used to treat a variety of conditions, including coronary artery disease, acute coronary syndrome, and peripheral arterial disease. It is a monoclonal antibody that binds to the platelet glycoprotein IIb/IIIa receptor, preventing platelet aggregation and thrombus formation. Abciximab is administered intravenously and is used in combination with other drugs, such as aspirin and heparin, to reduce the risk of thrombotic complications. It is also used to reduce the risk of thrombotic complications in patients undergoing percutaneous coronary intervention. Abciximab is a widely used drug in the hematological market, and is available in both generic and branded formulations. It is manufactured by several pharmaceutical companies, including Merck, Pfizer, and Bristol-Myers Squibb. Show Less Read more